Identification of the minimal glycopeptide core recognized by T cells in a model for rheumatoid arthritis

被引:18
作者
Holm, L
Kjellén, P
Holmdahl, R
Kihlberg, J [1 ]
机构
[1] Umea Univ, Dept Chem, SE-90187 Umea, Sweden
[2] Lund Univ, Sect Med Inflammat Res, SE-22184 Lund, Sweden
[3] AstraZeneca R&D Molndal, SE-43183 Molndal, Sweden
关键词
glycopeptide; collagen; T cell; rheumatoid arthritis;
D O I
10.1016/j.bmc.2004.10.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Collagen induced arthritis (CIA) is a common mouse model for rheumatoid arthritis. Two sets of truncated peptides derived from type II collagen have been prepared and tested for binding to A(q), a MHC-II molecule associated with development of CIA. Binding to A(q) correlated well with predictions from a computer-based model. T-cell hybridomas, obtained in CIA, were also used to study the ability of A(q) bound peptides to trigger a T-cell response. The minimal peptide epitope required for binding, as well as for giving a T-cell response, was determined to be CII260-267. In collagen this epitope is often glycosylated at hydroxylysine 264 and glycosylation has been shown to be an immunodominant feature in CIA. Synthesis and evaluation of CII260-267 carrying a beta-D-galactosyl moiety at position 264 revealed that this glycopeptide stimulated representative members from a panel of carbohydrate-specific T-cell hybridomas obtained in CIA. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:473 / 482
页数:10
相关论文
共 40 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   ALTERED REACTIVITY IN MIXED LYMPHOCYTE CULTURE OF LYMPHOCYTES FROM PATIENTS WITH RHEUMATOID ARTHRITIS [J].
ASTORGA, GP ;
WILLIAMS, RC .
ARTHRITIS AND RHEUMATISM, 1969, 12 (06) :547-&
[3]  
Bäcklund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO
[4]  
2-A
[5]   Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis [J].
Bäcklund, J ;
Carlsen, S ;
Höger, T ;
Holm, B ;
Fugger, L ;
Kihlberg, J ;
Burkhardt, H ;
Holmdahl, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9960-9965
[6]  
BRAND DD, 1994, J IMMUNOL, V152, P3088
[7]   T cells recognize a glycopeptide derived from type II collagen in a model for rheumatoid arthritis [J].
Broddefalk, J ;
Bäcklund, J ;
Almqvist, F ;
Johansson, M ;
Holmdahl, R ;
Kihlberg, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (31) :7676-7683
[8]   Preparation of a diglycosylated hydroxylysine building block used in solid-phase synthesis of a glycopeptide from type II collagen [J].
Broddefalk, J ;
Forsgren, M ;
Sethson, I ;
Kihlberg, J .
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (24) :8948-8953
[9]   ANTIBODIES TO TYPE-I, TYPE-II, TYPE-IX, AND TYPE-XI COLLAGEN IN THE SERUM OF PATIENTS WITH RHEUMATIC DISEASES [J].
CHARRIERE, G ;
HARTMANN, DJ ;
VIGNON, E ;
RONZIERE, MC ;
HERBAGE, D ;
VILLE, G .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :325-332
[10]  
Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO